Alcobra Company Profile (NASDAQ:ADHD)

About Alcobra

Alcobra logoAlcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and healthcare costs, higher divorce rates, lower levels of socioeconomic attainment, lower academic achievement, unemployment and work place deficits, increased risks for motor vehicle accidents, greater likelihood of additional psychiatric disorders, increased criminal activity and incarceration, and higher rates of substance use and abuse. MG01CI product has completed phase two studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADHD
  • CUSIP:
Key Metrics:
  • Previous Close: $4.62
  • 50 Day Moving Average: $4.76
  • 200 Day Moving Average: $4.52
  • 52-Week Range: $1.95 - $8.78
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.46
  • P/E Growth: 0.00
  • Market Cap: $69.18M
  • Outstanding Shares: 27,562,000
  • Beta: 1.2
Profitability:
  • Return on Equity: -34.95%
  • Return on Assets: -33.50%
Debt:
  • Current Ratio: 18.74%
  • Quick Ratio: 18.74%
Additional Links:
Companies Related to Alcobra:

Analyst Ratings

Consensus Ratings for Alcobra (NASDAQ:ADHD) (?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $8.86 (252.87% upside)

Analysts' Ratings History for Alcobra (NASDAQ:ADHD)
Show:
DateFirmActionRatingPrice TargetDetails
9/29/2016Piper Jaffray Cos.DowngradeOverweight -> NeutralView Rating Details
9/29/2016Oppenheimer Holdings Inc.DowngradeOutperform -> Market PerformView Rating Details
9/29/2016Cantor FitzgeraldDowngradeBuy -> Hold$2.00View Rating Details
9/12/2016WBB SecuritiesDowngradeHold -> Sell$5.00 -> $4.00View Rating Details
9/1/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
8/25/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/1/2016Barclays PLCInitiated CoverageEqual Weight$8.00View Rating Details
6/21/2016Roth CapitalReiterated RatingBuy$12.00View Rating Details
6/7/2016Canaccord GenuityInitiated CoverageBuyView Rating Details
11/17/2014AegisDowngradeBuy -> HoldView Rating Details
10/23/2014FBR & CoDowngradeOutperform -> Market Perform$22.00 -> $4.00View Rating Details
10/6/2014ING GroupReiterated RatingBuyView Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Alcobra (NASDAQ:ADHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/17/2016        
8/30/2016Q216($0.22)($0.21)ViewListenView Earnings Details
5/16/2016Q116($0.22)($0.18)ViewListenView Earnings Details
2/17/2016Q415($0.24)($0.20)ViewListenView Earnings Details
11/17/2015Q315($0.31)($0.20)ViewN/AView Earnings Details
8/13/2015Q215($0.30)($0.24)ViewListenView Earnings Details
5/6/2015($0.31)($0.26)ViewN/AView Earnings Details
2/12/2015Q4($0.57)($0.50)ViewN/AView Earnings Details
11/17/2014Q3 14($0.56)($0.77)ViewN/AView Earnings Details
8/11/2014Q2($0.57)($0.57)ViewListenView Earnings Details
5/15/2014Q114($0.57)ViewN/AView Earnings Details
2/13/2014Q413($0.35)($0.45)ViewN/AView Earnings Details
11/7/2013Q313($0.28)ViewN/AView Earnings Details
8/6/2013Q213($0.06)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alcobra (NASDAQ:ADHD)
Current Year EPS Consensus Estimate: $-0.96 EPS
Next Year EPS Consensus Estimate: $-1.02 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.19)($0.15)($0.17)
Q2 20163($0.22)($0.20)($0.21)
Q3 20163($0.29)($0.26)($0.27)
Q4 20163($0.34)($0.28)($0.32)
Q1 20171($0.22)($0.22)($0.22)
Q2 20171($0.18)($0.18)($0.18)
Q3 20171($0.18)($0.18)($0.18)
Q4 20171($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Alcobra (NASDAQ:ADHD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alcobra (NASDAQ:ADHD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Alcobra (NASDAQ:ADHD)
DateHeadline
streetinsider.com logoUnusual 11 Mid-Day Movers 9/29: (ITCI) (ADHD) (MRNS) Higher; (CATB) (AEGR) (DRNA) Lower - StreetInsider.com (NASDAQ:ADHD)
www.streetinsider.com - September 29 at 3:17 PM
smarteranalyst.com logoAnalysts Chime in on Two Volatile Biotech Stocks: Catabasis Pharmaceuticals Inc (CATB), Alcobra Ltd (ADHD) - Smarter Analyst (NASDAQ:ADHD)
www.smarteranalyst.com - September 29 at 3:17 PM
benzinga.com logo12 Biggest Mid-Day Losers For Thursday - Benzinga (NASDAQ:ADHD)
www.benzinga.com - September 29 at 3:17 PM
finance.yahoo.com logoAlcobra Pharma downgraded by Cantor Fitzgerald (NASDAQ:ADHD)
finance.yahoo.com - September 29 at 3:17 PM
thestreet.com logoAlcobra (ADHD) Stock Tumbles on FDA Clinical Hold, Cantor Remains Bullish (NASDAQ:ADHD)
www.thestreet.com - September 29 at 3:17 PM
finance.yahoo.com logoAlcobra Tumbles on FDA Clinical Hold (NASDAQ:ADHD)
finance.yahoo.com - September 29 at 3:17 PM
insidermonkey.com logoHere’s Why These Five Stocks Are in the Spotlight Today (NASDAQ:ADHD)
www.insidermonkey.com - September 29 at 3:17 PM
rttnews.com logoADHD Doesn't MEASURE Up, AMGN ARISEs To The Occasion, ITCI Misses Study Goal - RTT News (NASDAQ:ADHD)
www.rttnews.com - September 29 at 8:04 AM
streetinsider.com logoAlcobra Ltd. (ADHD) Reports Full Clinical Hold on IND Applications for MDX and Phase III MEASURE Study - StreetInsider.com (NASDAQ:ADHD)
www.streetinsider.com - September 29 at 8:04 AM
publicnow.com logoAlcobra Announces IND Clinical Hold Affecting the MDX Phase III MEASURE Study (NASDAQ:ADHD)
www.publicnow.com - September 29 at 8:04 AM
finance.yahoo.com logo2:57 am Alcobra Pharma receives notice of clinical hold from FDA for co's MDX Phase III MEASURE study (NASDAQ:ADHD)
finance.yahoo.com - September 29 at 8:04 AM
News IconLatest Analyst Reports On Alcobra Ltd. - NewsDen (NASDAQ:ADHD)
newsden.net - September 28 at 3:17 PM
News IconEarnings According to Analysts for Alcobra Ltd. (NASDAQ:ADHD)? - Frisco Fastball (NASDAQ:ADHD)
friscofastball.com - September 20 at 3:18 PM
News IconHodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Market H2 2016 Global Review Research (NASDAQ:ADHD)
www.traderplanet.com - September 19 at 8:03 AM
News IconAlcobra Limited Ord (NASDAQ:ADHD) Shorts Decreased by 0.85% After Short Covering - Frisco Fastball (NASDAQ:ADHD)
friscofastball.com - September 14 at 3:19 PM
News IconAlcobra Ltd. (ADHD) Cut to “Sell” at WBB Securities - National Daily Press (NASDAQ:ADHD)
www.nationaldailypress.com - September 13 at 8:05 AM
News IconStock Falling Lower in Trade: Alcobra Ltd. (NASDAQ:ADHD) - Post News (NASDAQ:ADHD)
www.kentuckypostnews.com - September 12 at 3:18 PM
News IconAlcobra Ltd. (NASDAQ:ADHD): How Are Analysts Advising to Play This Stock? - Post News (NASDAQ:ADHD)
www.kentuckypostnews.com - September 12 at 8:05 AM
News IconNoticeable Earnings Watch: Alcobra Ltd (NASDAQ:ADHD) - Post Registrar (NASDAQ:ADHD)
postregistrar.com - August 31 at 3:19 PM
finance.yahoo.com logoEdited Transcript of ADHD earnings conference call or presentation 30-Aug-16 12:30pm GMT (NASDAQ:ADHD)
finance.yahoo.com - August 31 at 8:04 AM
investornewswire.com logoCan Shares Of Alcobra Ltd. (NASDAQ:ADHD) Get To $17? - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - August 30 at 3:18 PM
fxpips.com logoCompany Earnings Report Before Market Opens (NASDAQ:ADHD)
www.fxpips.com - August 30 at 12:20 PM
sg.finance.yahoo.com logoAlcobra reports 2Q loss (NASDAQ:ADHD)
sg.finance.yahoo.com - August 30 at 12:20 PM
publicnow.com logoAlcobra Announces Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:ADHD)
www.publicnow.com - August 30 at 12:20 PM
investornewswire.com logoAlcobra Ltd. (NASDAQ:ADHD) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - August 23 at 9:32 AM
News IconSell-side Price Target Review on Alcobra Ltd. (NASDAQ:ADHD) - Post News (NASDAQ:ADHD)
www.kentuckypostnews.com - August 22 at 8:05 AM
investornewswire.com logoWill Alcobra Ltd. (NASDAQ:ADHD) Hit $17 Price Target? - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - August 16 at 3:19 PM
publicnow.com logoAlcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30 (NASDAQ:ADHD)
www.publicnow.com - August 15 at 10:33 AM
finance.yahoo.com logoIs a Surprise Coming for Alcobra (ADHD) This Earnings Season? (NASDAQ:ADHD)
finance.yahoo.com - August 9 at 12:03 PM
finance.yahoo.com logoWhat's in Store for Adverum (ADVM) this Earnings Season? (NASDAQ:ADHD)
finance.yahoo.com - August 8 at 3:19 PM
ftsenews.co.uk logoNew Broker Ratings For Alcobra Ltd. (ADHD) - FTSE News.co.uk - FTSE News (NASDAQ:ADHD)
www.ftsenews.co.uk - August 5 at 8:43 PM
finance.yahoo.com logoAlcobra (ADHD) Looks Good: Stock Adds 14.4% in Session (NASDAQ:ADHD)
finance.yahoo.com - August 4 at 11:49 AM
breakingfinancenews.com logoAlcobra Ltd (NASDAQ:ADHD) price target upped to $8 as recorded today by Barclays Capital (NASDAQ:ADHD)
breakingfinancenews.com - August 1 at 8:05 AM
investornewswire.com logoCan Shares Of Alcobra Ltd. (NASDAQ:ADHD) Hit $17? - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - July 26 at 3:21 PM
News IconStock Displaying Signs of a Downtrend: Alcobra Ltd. (NASDAQ:ADHD) - Press Telegraph (NASDAQ:ADHD)
presstelegraph.com - July 23 at 3:18 PM
News IconWere Analysts Bullish Alcobra Ltd (NASDAQ:ADHD) This Week? - Consumer Eagle (NASDAQ:ADHD)
www.consumereagle.com - July 22 at 3:17 PM
globenewswire.com logoAlcobra Granted European Orphan Drug Designation for Metadoxine in Fragile X Syndrome (NASDAQ:ADHD)
globenewswire.com - July 19 at 8:45 PM
kcregister.com logoChina Metro-Rural Holdings Limited (NYSEMKT:CNR) plummeted -15.07% : Alcobra Ltd. (NASDAQ:ADHD ... - KC Register (NASDAQ:ADHD)
www.kcregister.com - July 19 at 3:18 PM
investornewswire.com logoIs $17 Price Target Attainable For Alcobra Ltd. (NASDAQ:ADHD)? - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - July 19 at 9:30 AM
streetinsider.com logoAlcobra Ltd. (ADHD) Granted EC Orphan Drug Designation for Metadoxine in Fragile X Syndrome - StreetInsider.com (NASDAQ:ADHD)
www.streetinsider.com - July 19 at 9:30 AM
News IconAlcobra Limited Ord (NASDAQ:ADHD) Shorts Decreased by 3.56% After Short Covering - Consumer Eagle (NASDAQ:ADHD)
www.consumereagle.com - July 16 at 3:19 PM
ftsenews.co.uk logoNew Broker Ratings For Alcobra Ltd. (ADHD) - FTSE News (NASDAQ:ADHD)
www.ftsenews.co.uk - July 15 at 7:35 PM
investornewswire.com logoStrong Sell Calls For Alcobra Ltd. (NASDAQ:ADHD) At 0 - Investor Newswire (NASDAQ:ADHD)
www.investornewswire.com - July 12 at 9:20 AM
News IconAlcobra Limited Ord (NASDAQ:ADHD) Short Interest Decreased By 3.56% - Engelwood Daily (NASDAQ:ADHD)
www.engelwooddaily.com - July 10 at 3:18 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Alcobra Ltd. (ADHD) - Fiscal Standard (NASDAQ:ADHD)
www.fiscalstandard.com - July 10 at 8:03 AM
kcregister.com logoInvestors Watch List: Alcobra Ltd. (NASDAQ:ADHD), KeyCorp. (NYSE:KEY), Symantec Corporation (NASDAQ:SYMC ... - KC Register (NASDAQ:ADHD)
www.kcregister.com - July 8 at 3:20 PM
News IconHow Many Alcobra Ltd (NASDAQ:ADHD)'s Analysts Are Bullish? - Press Telegraph (NASDAQ:ADHD)
presstelegraph.com - July 7 at 3:19 PM
fiscalstandard.com logoBroker Outlook For Alcobra Ltd. (ADHD) - Fiscal Standard (NASDAQ:ADHD)
www.fiscalstandard.com - July 6 at 3:19 PM
globenewswire.com logoAlcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference - GlobeNewswire (press release) (NASDAQ:ADHD)
globenewswire.com - July 5 at 3:18 PM
finance.yahoo.com logoAlcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference (NASDAQ:ADHD)
finance.yahoo.com - July 5 at 8:00 AM

Social

Alcobra (NASDAQ:ADHD) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff